drugset / Trial / NCT07108933

Scheduled Autologous PRP Guided Injection in the Maxillary Bony Defects

NCT07108933

Phase 2 Completed 16 enrolled Horus University
NaSingle-groupOpen-labelTreatment

Summary

Scheduled autologous platelet-rich plasma guided injection is done in critical-sized maxillary bony defects after surgical excision of non- malignant lesions.

Timeline

Start
2023-08-15
Primary completion
2024-10-15
Completion
2025-04-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Platelet Rich Plasma Other / unclassified Other